Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-11-13 | New | $350,000 | $350,000 | Debt Only | 06b | SEC link |
| 2024-11-13 | New | $1,231,591 | $1,231,591 | Equity and Debt | 06b | SEC link |
| 2024-10-23 | New | $674,200 | $674,200 | Equity Only | 06b | SEC link |
| 2018-09-12 | New | $497,632 | $497,632 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jill Buzan | Executive |
| Sergio Castillo | Executive |
| Wendell Hecker | Executive |
| Gagan Hunter | Director, Executive |
| Giorgio R Saumat | Executive |
| Nickolas S Tabraue | Director, Executive, Promoter |
| Steven Warm | Director |